|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.39% | +1.93% | -10.28% | -29.30% | 241B | ||
| +0.55% | +0.45% | -43.01% | -54.59% | 41.26B | ||
| +2.27% | +2.13% | -39.77% | -49.35% | 21.58B | ||
| -4.26% | -7.93% | -41.34% | -65.64% | 17.16B | ||
| -0.79% | -2.96% | +17.83% | +50.95% | 11.22B | ||
| +0.64% | +0.77% | -46.29% | -71.14% | 8.76B | ||
| -0.72% | -1.83% | -11.93% | -51.61% | 8.06B | ||
| +1.88% | +3.59% | -42.74% | -65.39% | 6.57B | ||
| -0.11% | +2.08% | -33.34% | -51.70% | 5.28B | ||
| Average | -0.02% | -0.63% | -27.87% | -43.09% | 40.1B | |
| Weighted average by Cap. | +0.26% | -0.69% | -18.23% | -35.12% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















